| OP (n = 200) | IP (n = 101) | Significance |
---|---|---|---|
Age (years) | 37.9Â +Â 12.8 | 53.48Â +Â 15.6 | 0.0001 |
Gender | |||
 Male | 140 (70%) | 65 (64.4%) | 0.32 |
 Female | 60 (30%) | 36 (35.6%) | 0.32 |
 Asymptomatic | 81 (40.5%) | 0 | 0.0001 |
 Symptomatic | 119 (59.5%) | 101 (100%) | 0.0001 |
Disease Severity | |||
 Mild Symptoms | 119 (59.5%) | 90 (89%) | 0.0001 |
 Moderate Disease | nil | 8 (7.9%) | 0.0001 |
 Severe Disease | nil | 3 (2.9%) | 0.01 |
Comorbidities | |||
 Diabetes | 5 (2.5%) | 10 (9.9%) | 0.005 |
 Hypertension | 5 (2.5%) | 14 (13.9%) | 0.0001 |
 DM + HTN | 6 (3%) | 23 (22.8%) | 0.0001 |